Hashimoto encephalopathy: a case report and a short revision of current literature
Hashimoto encephalopathy in pediatric age
Keywords:
Hashimoto encephalopathy, adolescent, treatment, ThyroiditisAbstract
Hashimoto encephalopathy (HE) is a rare but controversial entity encompassing a variety of neuropsychological presentations in the setting of autoimmune thyroid disease. HE, mostly described in adults, with a female‑to‑male ratio of 4:1, is a relatively rare entity in the pediatric population and probably under recognized as a cause of acute encephalopathy in children and adolescents. A number of pathogenetic mechanisms have been suggested. Female prevalence, presence of autoantibodies, fluctuating course, and response to immunomodulatory therapy suggest the autoimmune nature of the disease. Existing diagnostic criteria for adults require modification to be applied to children and adolescents, who differ from adults in their clinical presentations, clinical findings, autoantibody profiles, treatment response, and long-term outcomes. A combination of neurological findings, positive antithyroid autoantibodies, and responsiveness to steroids is diagnostic of HE. We add a new case of HE in an adolescent girl and review the current HE literature.
References
, Brain L, Jellinek EH, Ball K. Hashimoto’s disease and encephalopathy. Lancet. 1966; 2:512–514.
Hashimoto Encephalopathy Case Reports. Turk J Anaesthesiol Reanim. 2018;46:402-405.
Sharma PM, Javali M, Mahale R, Madhusudhan BK, Majeed AA, Srinivasa R. Hashimoto encephalopathy: a study of the clinical profile, radiological and electrophysiological correlation in a
tertiary care center in South India. J Neurosci Rural Pract. 2015;6:309–314.
Mattozzi S, Sabater L, Escudero D, et al. Hashimoto encephalopathy in the 21st century. Neurology. 2020;94:e217-e224.
Kutluk MG, Haznedar P, Bektas O, et al. Hashimoto's Encephalopathy in Children: Different Manifestations of Five Case. Acta Neurol Belg. 2019;119:595-599.
Ferracci F, Bertiato G, Moretto G. Hashimoto’s encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci. 2004;217:165–168.
Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006;63:197–202.
Mahad DJ, Staugaitis S, Ruggieri P, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci. 2005;228:3–5.
Caselli RJ, Boeve BF, Scheithauer BW, O’Duffy JD, Hunder GG. Non-vasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology. 1999; 53:1579–1581.
Alink J, de Vries TW. Unexplained seizures, confusion or hallucinations: think Hashimoto encephalopathy. Acta Paediatr. 2008;97:451–453.
Montagna G, Imperiali M, Agazzi P, et al. Hashimoto’s encephalopathy: a rare proteiform disorder. Autoimmun Rev. 2016;15:466–476.
Arrojo M, Perez-Rodriguez MM, Mota M, et al. Psychiatric presentation of Hashimoto's encephalopathy. Psychosom Med. 2007;69:200-201.
Deutsch M, Koskinas J, Tzannos K, et al. Hashimoto's encephalopathy with pegylated interferon alfa-2b and ribavirin. Ann Pharmacother. 2005;39:1745-1748.
Hori T, Oike F, Hata K, et al. Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epsteine-Barr virus infection. Transpl Infect Dis. 2010;12:347-352.
Sellal F, Berton C, Andriantseheno M, Clerc C. Hashimoto's encephalopathy: Exacerbations associated with menstrual cycle. Neurology. 2002;59:1633-1635.
Nagamine M, Yoshino A, Ishii M, et al. Lithium-induced Hashimoto's encephalopathy: a case report. Bipolar Disord. 2008;10:846-848.
Ferracci F, Carnevale A. The neurological disorder associated with thyroid autoimmunity. J Neurol. 2006;253:975–984.
Graham BR, Shiff N, Nour M, Hasal S, Huntsman R, Almubarak S. Hashimoto encephalopathy presenting with stroke-like episodes in an adolescent female: a case report and literature review. Pediatr Neurol. 2016;59:62–70.
Watemberg N, Greenstein D, Levine A. Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective. J Child Neurol. 2006;21:1–5.
Ferracci F, Moretto G, Candeago RM, et al. Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto's encephalopathy. Neurology. 2003;60:712-714.
Bertoni M, Falcini M, Sestini S, Niccoli L, Nannini C, Cantini F. Encephalopathy associated with Hashimoto's thyroiditis :anadditional case. Eur J Intern Med. 2003;14:434-437.
Chun JK, LeeTJ, Choi KM,Lee KH, KimDS.Elevated anti-alpha-enolase antibody levels in Kawasaki disease. Scand J Rheumatol. 2008;37: 48–52.
Yoneda M. Hashimoto’s Encephalopathy and Autoantibodies. Brain Nerve 2018; 70:305–314.
Blanchin S, Coffin C, Viader F, et al. Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes. J Neuroimmunol. 2007;192:13-20.
Mamoudjy N, Korff C, Maurey H, et al. Hashimoto’s encephalopathy: identification and long- term outcome in children. Eur J Paediatr Neurol.2013;17:280– 287.
Ishii K, A. Hayashi A,Tamaoka A, Usuki S, Mizusawa H, Shoji S. Case report: thyrotropin-releasing hormone-induced myoclonus and tremor in a patient with Hashimoto’s encephalopathy. Am J Med Sci. 1995;310:202–205.
Lee MJ, Lee HS, Hwang JS, Jung DE. A case of Hashimoto’s encephalopaty presenting with seizures and psychosis. Korean J Pediatr. 2012;55:111-113.
Vasconcellos E, Pina-Garza JE, Fakhoury T, Fenichel GM. Pediatric manifestations of Hashimoto’s encephalopathy. Pediatr Neurol. 1999;20:394–398.
Chaigne B, Mercier E, Garot D, Legras A, Dequin PF, Perrotin D. Hashimoto’s encephalopathy in the intensive care unit. Neurocrit Care. 2013;18:386–390.
Gul Mert G, Horoz OO, Herguner MO, et al. Hashimoto’s encephalopathy: four cases and review of literature. Int J Neurosci. 2014;124:302–306.
Tuncer GO, Teber S, Kutluk MG, Albayrak P, Deda G. Hashimoto's Encephalopathy Presenting as Pseudobulbar Palsy. Case Reports Childs Nerv Syst. 2018;34:1251-1254.
Beckmann YY, Top D, Yigit T. Unusual presentations of Hashimoto’s encephalopathy: trigeminal neuralgiaform headache, skew deviation, hypomania. Endocrine. 2011;40:495–496.
Salazar R, Mehta C, Zaher N, Miller D. Opsoclonus as a manifestation of Hashimoto’s encephalopathy. J. Clin. Neurosci. 2013;19:1465–1466.
Sharan A, SenguptaS, Mukhopadhyay S, Ghosh B. Hashimoto’s Encephalopathy Presenting with Chorea. J Assoc Physicians India. 2015;63:83–84.
Ueno H, Nishizato C, Shimazu T, et al. Hashimoto’s encephalopathy presenting with vertigo and muscle weakness in a male pediatric patient. No Hattatsu. 2016;48:45–47.
Emeksiz S, Kutlu NO, Alacakir N, Caksen H. A case of steroid-resistance Hashimoto’s encephalopathy presenting with sensorimotor polyneuropathy. Turk. J. Pediatr. 2018;60:310–314.
Paterson RW, Takada LT, Geschwind MD. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract. 2012;2:187–200.
Fayyaz B, Upreti S.Autoimmune inner ear disease secondary to Hashimoto’s thyroiditis: a case report. J Community Hosp Intern Med Perspect. 2018;8:227-229.
Zhu Y, Yang H, Xiao F. Hashimoto's encephalopathy: a report of three cases and relevant literature reviews. Int J Clin Exp Med. 2015;8:16817-16826.
Salpietro V, Mankad K, Polizzi A, et al. Pediatric Hashimoto's encephalopathy with peripheral nervous system involvement. Pediatr Int. 2014;56:413-416.
Peschen-Rosin R, Schabet M, Dichgans J. Manifestation of Hashimoto’s encephalopathy years before onset of thyroid disease. Eur Neurol. 1999;41:79–84.
Graus F, Titulaer MJ, Balu R, et al. A clinicalapproach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404.
Muhle H, van Baalen A, Riepe FG, Rohr A, Stephani U. Hashimoto Encephalopathy in a 15-year-Old-Girl: EEG Findings and Follow-Up. Pediatr Neurol. 2009; 41:301-304.
Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy syndrome or myth? Arch Neurol 2003;60:164–171.
Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NEF.Hashimoto’s encephalopathy: A steroid-responsive disorder associated with high anti-thyroid antibody titers—report of 5 cases. Neurology. 1991;41:228-233.
Takahashi S, Mitamura R, Itoh Y, Suzuki N, Okuno A.Hashimoto encephalopathy: Etiologic considerations. Pediatr Neurol. 1994;11:328-331.
Kelley BP, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, GriffithB. Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. AJNR Am J Neuroradiol. 2017; 38:1070–1078.
Devon IR. Hashimoto encephalopathy. UpToDate. Jul 10, 2017.
MahmudFH, Lteif AN, Renaud DL, Reed AM, Brands CK. Steroid-responsive Encephalopathy associated with Hashomoto’s Thyroiditis in an Adolescent With Chronic Hallucinations and Depression: Case Report and Review. Pediatrics. 2003;112:686-90.
Drulovic J, Andrejevic S, Bonaci-Nikolic B, et al. Hashimoto's encephalopathy: a long-lasting remission induced by intravenous immunoglobulins. Vojnosanit Pregl 2011;68(5):452-4.
Churilov LP, Sobolevskaia PA, Stroev YI. Thyroid gland and brain: Enigma of Hashimoto’s encephalopathy. Best Pract Res Clin Endocrinol Metab. 2019;33:101364. doi:10.1016/j.beem.2019.101364
Attique HB, Rao A, Haider L, Trivedi R. Successful treatment of Hashimoto encephalopathy with therapeutic plasma exchange. Ther Apher Dial. 2019;10.1111/1744-9987.13466. doi:10.1111/1744-9987.13466.
Cook MK, Malkin M, Karafin MS. The use of plasma exchange in Hashimoto’s encephalopathy: a case report and review of the literature. J Clin Apheresis. 2015;30:188–192.
Jiang Y, Tian X, Gu Y, Li F, Wang X. Application of Plasma Exchange in Steroid-Responsive Encephalopathy. Front Immunol. 2019;10:324. Published 2019 Feb 27. doi:10.3389/fimmu.2019.00324.
Lee J, Yu HJ, Lee J. Hashimoto encephalopathy in pediatric patients: Homogeneity in clinical presentation and heterogeneity in antibody titers. Brain Dev. 2018;40:42-48.
Erol I, Sayg S, Alehan F. Hashimoto’s encephalopathy in children and adolescents. Pediatr Neurol. 2011;45:420-422.
Garg M, Sharma SD, Hajela A, Gupta P . Hashimoto Encephalopathy in Children. Ann Indian
Acad Neurol. 2019; 22: 357–359.
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
